Peter Dannenbaum | Vice President-Investor Relations |
Ken Frazier | Chairman and Chief Executive Officer |
Rob Davis | Chief Financial Officer |
Roger Perlmutter | President-Merck Research Laboratories |
Frank Clyburn | Chief Commercial Officer |
Mike Nally | Chief Marketing Officer |
Andrew Baum | Citi |
Umer Raffat | Evercore ISI |
Terence Flynn | Goldman Sachs |
Louise Chen | Cantor |
David Risinger | Morgan Stanley |
Seamus Fernandez | Guggenheim |
Daina Graybosch | SVB Leerink |
Chris Schott | J.P. Morgan |
Good morning. My name is Laura, and that will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. Q2 Sales and Earnings Conference Call. All lines have been placed in mute to prevent any background noise.